TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
RLAY

Relay Therapeutics Inc

Healthcare · Biotechnology

17.70$ -1.7% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement RLAY
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– – 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
– – 4.3% 5,592.2% 17,596.3% 1,277.6% 3,152.2% 23.2%
– – 95.7% -5,492.2% -17,496.3% -1,177.6% -3,052.2% 76.8%
– – 120.8% 9,760.6% 17,838.9% 1,291.9% 3,188.7% 1,702.3%
– – 46.7% 1,831.8% 4,712.9% 291.0% 759.4% 369.3%
– – 163.2% 6,548.0% 4,174.6% 282.5% 669.9% 2,048.4%
– – -67.5% -12,040.2% -21,670.9% -1,460.1% -3,722.1% -1,971.6%
– – 0.0% 27.3% 634.8% – – –
– – -63.4% -12,012.9% -21,036.1% -1,338.7% -3,374.7% -1,800.6%
– – -4.1% 4,388.8% -2,624.9% -146.7% -3,374.7% –
– – -63.4% -12,012.9% -21,036.1% -1,338.7% -3,374.7% -1,800.6%
– – -63.2% -7,364.9% -22,217.4% -1,464.6% -3,799.4% -1,777.4%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?